![](https://static.wixstatic.com/media/613266_6da99b39000846509ce855460ba8dac7~mv2.jpg/v1/fill/w_980,h_1312,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/613266_6da99b39000846509ce855460ba8dac7~mv2.jpg)
![](https://static.wixstatic.com/media/613266_cb6e166927de476ea8349e8460e5e596~mv2.jpg/v1/fill/w_967,h_858,al_c,q_85,enc_avif,quality_auto/613266_cb6e166927de476ea8349e8460e5e596~mv2.jpg)
![TB4](https://static.wixstatic.com/media/613266_890211981e89410da8eabd22e3821757~mv2.jpg/v1/fill/w_977,h_1264,al_c,q_85,enc_avif,quality_auto/613266_890211981e89410da8eabd22e3821757~mv2.jpg)
![](https://static.wixstatic.com/media/613266_6da99b39000846509ce855460ba8dac7~mv2.jpg/v1/fill/w_980,h_1312,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/613266_6da99b39000846509ce855460ba8dac7~mv2.jpg)
The Bergsbaken Lab is part of the Center for Immunity and Inflammation at Rutgers New Jersey Medical School in Newark, NJ.
Our lab studies a subset of CD8+ T cells that traffic to the tissue and persist there after infection or immunization. These tissue-resident memory T cells (Trm) play an important role in early defense against pathogen challenge at barrier surfaces. We use bacterial and viral pathogens to understand the mechanisms of T cell activation, maintenance, and function in the intestine and other mucosal tissues in response to local infection.
The density of CD8+ T cells within solid tumors often correlates with improved prognosis, and our lab is also utilizing a mouse model of colorectal cancer to examine how adoptive CD8+ T cell immunotherapy can be improved using our findings from infection models.